Roukounas patent opposition analysis

The comprehensive analysis of Roukounas opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Roukounas

Patent NumberTitleApplicantOpposition DateOpposition Company
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISNov 4, 2022GENEPHARM
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 20, 2022ELPEN PHARMACEUTICAL
Aqueous Pharmaceutical Formulation Of Tapentadol For Oral AdministrationGRNENTHALJan 22, 2021LABOMED PHARMACEUTICAL COMPAMY

Top companies who are the clients of Roukounas